At Samsara BioCapital, we partner with scientists and entrepreneurs to translate cutting-edge science into transformative medicines for patients. We feel incredibly fortunate to invest during a prolific time for biotech and to partner with inspiring companies developing groundbreaking therapies. Our culture is centered on a shared vision: making a significant impact on patients' lives by supporting the development of innovative new treatments.
| Website | http://samsaracap.com/ |
| Revenue | $5.4 million |
| Employees | 36 (31 on RocketReach) |
| Founded | 2016 |
| Address | 628 Middlefield Rd, Palo Alto, California, US |
| Technologies |
JavaScript
,
HTML
,
PHP
+5 more
(view full list)
|
| Industry | Venture Capital and Private Equity Principals |
| Keywords | Biotech Venture Capital, Life Science Venture Capital, Pharmaceutical Funding, Biopharmaceutical Investment, Life Science Investing, Healthcare Venture Capital, Early Stage Biotech, Biotech Startups, Clinical Stage Investment, Medtech Investment, Pharmaceutical Startups |
| Competitors | Third Rock Ventures, RA Capital Management, L.P., Atlas Venture, Versant Ventures, Frazier Healthcare Partners, OrbiMed, Flagship Pioneering, Sofinnova Investments, ARCH Venture Partners, Accelmed +32 more (view full list) |
Looking for a particular Samsara BioCapital employee's phone or email?
The Samsara BioCapital annual revenue was $5.4 million in 2026.
Miran Ahmad is the CFO of Samsara BioCapital.
31 people are employed at Samsara BioCapital.
Samsara BioCapital is based in Palo Alto, California.